159 related articles for article (PubMed ID: 14530492)
1. Overlooked contributions on sodium iodide symporter.
Dadachova E; Zuckier LS
J Nucl Med; 2003 Oct; 44(10):1707. PubMed ID: 14530492
[No Abstract] [Full Text] [Related]
2. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
3. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
[TBL] [Abstract][Full Text] [Related]
4. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene.
Lee YJ; Chung JK; Shin JH; Kang JH; Jeong JM; Lee DS; Lee MC
Thyroid; 2004 Nov; 14(11):889-95. PubMed ID: 15671766
[TBL] [Abstract][Full Text] [Related]
6. The sodium iodide symporter: its pathophysiological and therapeutic implications.
Spitzweg C; Morris JC
Clin Endocrinol (Oxf); 2002 Nov; 57(5):559-74. PubMed ID: 12390328
[TBL] [Abstract][Full Text] [Related]
7. The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound.
Meller J; Becker W
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S425-38. PubMed ID: 12192542
[TBL] [Abstract][Full Text] [Related]
8. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
[TBL] [Abstract][Full Text] [Related]
9. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the sodium/iodide symporter explains 131I-induced thyroid stunning.
Nordén MM; Larsson F; Tedelind S; Carlsson T; Lundh C; Forssell-Aronsson E; Nilsson M
Cancer Res; 2007 Aug; 67(15):7512-7. PubMed ID: 17671222
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced thyroid stunning: differential effects of (123)I, (131)I, (99m)Tc, and (211)At on iodide transport and NIS mRNA expression in cultured thyroid cells.
Lundh C; Lindencrona U; Postgård P; Carlsson T; Nilsson M; Forssell-Aronsson E
J Nucl Med; 2009 Jul; 50(7):1161-7. PubMed ID: 19525464
[TBL] [Abstract][Full Text] [Related]
12. Radioiodide imaging and treatment of ARO cancer xenograft in a mouse model after expression of human sodium iodide symporter.
Hsieh YJ; Ke CC; Liu RS; Wang FH; Tang KT; Chi CW; Chen FD; Lee CH
Anticancer Res; 2007; 27(4B):2515-22. PubMed ID: 17695547
[TBL] [Abstract][Full Text] [Related]
13. Sodium iodide symporter in the fight against thyroid cancer.
Kogai T
Future Oncol; 2013 Nov; 9(11):1679-82. PubMed ID: 23800189
[No Abstract] [Full Text] [Related]
14. Evaluation of toxicological hazards from medical radioiodine administration.
Van Dyke M; Punja M; Hall MJ; Kazzi Z
J Med Toxicol; 2015 Mar; 11(1):96-101. PubMed ID: 25008160
[No Abstract] [Full Text] [Related]
15. [Use of radioisotopes in thyroid diagnosis in pediatrics].
Mussa GC; Bona G; Silvestro L
Minerva Pediatr; 1979 Apr; 31(7):487-96. PubMed ID: 460100
[No Abstract] [Full Text] [Related]
16. Radionuclide imaging of the thyroid gland: patterns, pearls, and pitfalls.
Smith JR; Oates E
Clin Nucl Med; 2004 Mar; 29(3):181-93. PubMed ID: 15162989
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor expression in the thyroid demonstrated with 111In-octreotide scintigraphy.
Becker W; Schrell U; Buchfelder M; Hensen J; Wendler J; Gramatzki M; Wolf F
Nuklearmedizin; 1995 Jun; 34(3):100-3. PubMed ID: 7630741
[TBL] [Abstract][Full Text] [Related]
18. [Radionuclide diagnosis of thyroid diseases].
Slavnov VN
Vrach Delo; 1984 Sep; (9):54-9. PubMed ID: 6209859
[No Abstract] [Full Text] [Related]
19. Translational research using the sodium/iodide symporter in imaging and therapy.
Chung JK; Kang JH
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):799-802. PubMed ID: 14770271
[No Abstract] [Full Text] [Related]
20. A target lesion of the thyroid.
Alter AJ; Vega RJ
Clin Nucl Med; 1988 Mar; 13(3):211. PubMed ID: 3289822
[No Abstract] [Full Text] [Related]
[Next] [New Search]